Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between genetic polymorphisms of telomere pathway genes and hydrogen peroxide level in omethoate exposure workers. | Environ Toxicol Pharmacol | 2021 | 33161111 | PubTator, text mining | PubMed |
| The multifunctional APE1 DNA repair-redox signaling protein as a drug target in human disease. | Drug Discov Today | 2021 | 33148489 | PubTator, text mining | PubMed |
| Telomeric alterations in the default mode network during the progression of Alzheimer's disease: Selective vulnerability of the precuneus. | Neuropathol Appl Neurobiol | 2021 | 33107640 | PubTator, text mining | PubMed |
| Cancer-associated mutations in the condensin II subunit CAPH2 cause genomic instability through telomere dysfunction and anaphase chromosome bridges. | J Cell Physiol | 2021 | 33078399 | PubTator, text mining | PubMed |
| Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma. | J Med Genet | 2021 | 32994281 | PubTator, text mining | PubMed |
| Loss-of-function variants in POT1 predispose to uveal melanoma. | J Med Genet | 2021 | 32907878 | PubTator, text mining | PubMed |
| Decreased expression of TERT and telomeric proteins as human ovaries age may cause telomere shortening. | J Assist Reprod Genet | 2021 | 32856217 | PubTator, text mining | PubMed |
| Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study. | J Natl Cancer Inst | 2021 | 32577730 | PubTator, text mining | PubMed |
| Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study. | Haematologica | 2021 | 32273480 | PubTator, text mining | PubMed |
| Investigation of conformational dynamics of Tyr89Cys mutation in protection of telomeres 1 gene associated with familial melanoma. | J Biomol Struct Dyn | 2021 | 31847782 | PubTator, text mining | PubMed |
| Promises and pitfalls of targeted agents in chronic lymphocytic leukemia. | Cancer Drug Resist | 2020 | 35582452 | PubTator, text mining | PubMed |
| Identification of key regulators in parathyroid adenoma using an integrative gene network analysis. | Bioinformation | 2020 | 34803267 | PubTator, text mining | PubMed |
| Replication protein A: a multifunctional protein with roles in DNA replication, repair and beyond. | NAR Cancer | 2020 | 34316690 | PubTator, text mining | PubMed |
| The Genetic Germline Background of Single and Multiple Primary Melanomas. | Front Mol Biosci | 2020 | 33748184 | PubTator, text mining | PubMed |
| Multi-Omics Driven Metabolic Network Reconstruction and Analysis of Lignocellulosic Carbon Utilization in Rhodosporidium toruloides. | Front Bioeng Biotechnol | 2020 | 33585414 | PubTator, text mining | PubMed |
| Telomere Dysfunction in Chronic Lymphocytic Leukemia. | Front Oncol | 2020 | 33520723 | PubTator, text mining | PubMed |
| DNA Methylation in Ovarian Cancer Susceptibility. | Cancers (Basel) | 2020 | 33396385 | PubTator, text mining | PubMed |
| Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome. | Front Immunol | 2020 | 33381116 | PubTator, text mining | PubMed |
| Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies. | Int J Mol Sci | 2020 | 33374413 | PubTator, text mining | PubMed |
| A Label-Free Cellular Proteomics Approach to Decipher the Antifungal Action of DiMIQ, a Potent Indolo[2,3-b]Quinoline Agent, against Candida albicans Biofilms. | Int J Mol Sci | 2020 | 33374351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers?page=47